Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HB-adMSCs by Hope Biosciences for Primary Lateral Sclerosis: Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase I for Primary Lateral Sclerosis. According to GlobalData,...
HB-adMSCs by Hope Biosciences for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...
HB-adMSCs by Hope Biosciences for Relapsing Remitting Multiple Sclerosis (RRMS): Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase II for Relapsing Remitting Multiple Sclerosis (RRMS). According...
HB-adMSCs by Hope Biosciences for Parkinson's Disease: Likelihood of Approval
HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...